News-Medical.Net September 10, 2024
University of British Columbia Okanagan campus

Feeling safe and comfortable are key when discussing your health and wellbeing with your primary care provider.

However, that feeling of comfort and safety can’t be taken for granted among many people who have turned to psychedelic substances-;including psilocybin-;to help control their symptoms of depression, anxiety or PTSD. Now, a team of UBC Okanagan researchers in the Irving K. Barber Faculty of Arts and Social Sciences has published a study looking into patient perspectives and potential issues when it comes to discussing psychedelics for therapeutic use with their physicians.

Dr. Michelle St. Pierre conducts research with Dr. Zach Walsh in UBC’s Therapeutic, Recreational, and Problematic Substance Use Lab. Their latest paper, published in Psychedelic Medicine, determined that concern about having...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Physician, Provider
How this health system builds its own behavioral health workforce
3 Ways ‘Rejection Sensitivity’ Ruins Your Mental Health—By A Psychologist
Why beds at this new behavioral health hospital are empty
Mental health parity: 3 updates
Arizona’s New Behavioral Healthcare Laws - Part 2

Share This Article